Surgery Partners, Inc. (SGRY) Expected to Post Quarterly Sales of $436.63 Million
Wall Street brokerages expect that Surgery Partners, Inc. (NASDAQ:SGRY) will report sales of $436.63 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for Surgery Partners’ earnings. The highest sales estimate is $471.70 million and the lowest is $410.17 million. Surgery Partners reported sales of $306.00 million during the same quarter last year, which indicates a positive year-over-year growth rate of 42.7%. The firm is expected to report its next earnings report on Thursday, March 8th.
According to Zacks, analysts expect that Surgery Partners will report full-year sales of $436.63 million for the current year, with estimates ranging from $1.29 billion to $1.35 billion. For the next fiscal year, analysts anticipate that the company will post sales of $1.80 billion per share, with estimates ranging from $1.75 billion to $1.90 billion. Zacks’ sales calculations are a mean average based on a survey of research analysts that cover Surgery Partners.
Several research firms have recently weighed in on SGRY. BidaskClub upgraded Surgery Partners from a “strong sell” rating to a “sell” rating in a research note on Tuesday, December 12th. Jefferies Group decreased their price target on Surgery Partners from $16.00 to $13.00 and set a “buy” rating on the stock in a research report on Wednesday, November 1st. KeyCorp restated a “hold” rating on shares of Surgery Partners in a research report on Tuesday, October 31st. Zacks Investment Research upgraded Surgery Partners from a “strong sell” rating to a “hold” rating in a research report on Wednesday, October 11th. Finally, Bank of America lowered Surgery Partners from a “buy” rating to a “neutral” rating and set a $19.00 price target on the stock. in a research report on Wednesday, November 1st. Four research analysts have rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $18.57.
Shares of Surgery Partners (NASDAQ:SGRY) opened at $11.15 on Friday. Surgery Partners has a 12 month low of $7.10 and a 12 month high of $24.05. The firm has a market capitalization of $475.50, a P/E ratio of 65.00 and a beta of 1.89. The company has a quick ratio of 1.92, a current ratio of 2.09 and a debt-to-equity ratio of 1.56.
Surgery Partners announced that its board has approved a share buyback program on Friday, December 15th that allows the company to buyback $50.00 million in outstanding shares. This buyback authorization allows the company to repurchase shares of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.
COPYRIGHT VIOLATION WARNING: “Surgery Partners, Inc. (SGRY) Expected to Post Quarterly Sales of $436.63 Million” was posted by Watch List News and is the property of of Watch List News. If you are accessing this story on another site, it was illegally copied and republished in violation of international copyright law. The correct version of this story can be accessed at https://www.watchlistnews.com/surgery-partners-inc-sgry-expected-to-post-quarterly-sales-of-436-63-million/1769253.html.
About Surgery Partners
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.